Wall Street Zen Downgrades Varex Imaging (NASDAQ:VREX) to Buy

Varex Imaging (NASDAQ:VREX) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday.

A number of other research analysts have also recently weighed in on VREX. B. Riley Financial reaffirmed a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a report on Monday, April 13th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $14.50 price objective on shares of Varex Imaging in a report on Monday, February 2nd. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a report on Friday, March 27th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $16.17.

Varex Imaging Stock Performance

NASDAQ VREX opened at $12.53 on Friday. Varex Imaging has a 1 year low of $6.76 and a 1 year high of $14.56. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.89 and a quick ratio of 1.87. The company has a fifty day moving average of $11.79 and a 200 day moving average of $12.15. The company has a market capitalization of $525.01 million, a PE ratio of -7.64 and a beta of 0.99.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.05. Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. The company had revenue of $209.60 million during the quarter, compared to analysts’ expectations of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. Research analysts forecast that Varex Imaging will post 0.93 earnings per share for the current year.

Insider Buying and Selling at Varex Imaging

In related news, Director Jay K. Kunkel sold 4,510 shares of the company’s stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $11.14, for a total transaction of $50,241.40. Following the completion of the transaction, the director owned 23,450 shares in the company, valued at $261,233. This represents a 16.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 4.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Varex Imaging by 4.4% during the 3rd quarter. Vanguard Group Inc. now owns 2,989,847 shares of the company’s stock worth $37,074,000 after purchasing an additional 126,396 shares during the last quarter. Cooke & Bieler LP raised its position in shares of Varex Imaging by 2.2% during the 4th quarter. Cooke & Bieler LP now owns 1,632,525 shares of the company’s stock worth $19,019,000 after purchasing an additional 35,042 shares during the last quarter. Neuberger Berman Group LLC raised its position in shares of Varex Imaging by 1.4% during the 3rd quarter. Neuberger Berman Group LLC now owns 1,518,674 shares of the company’s stock worth $18,810,000 after purchasing an additional 21,499 shares during the last quarter. LSV Asset Management raised its position in shares of Varex Imaging by 210.7% during the 4th quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock worth $14,496,000 after purchasing an additional 843,805 shares during the last quarter. Finally, Rice Hall James & Associates LLC raised its position in shares of Varex Imaging by 19.1% during the 4th quarter. Rice Hall James & Associates LLC now owns 1,082,964 shares of the company’s stock worth $12,617,000 after purchasing an additional 173,703 shares during the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.